Huilgol, N G <br/><br/>
An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Mar 1996 
 - 1121-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/0360-3016(95)02181-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Humans<br/>Middle Aged<br/>Neoplasm Staging<br/>Oropharyngeal Neoplasms--pathology<br/>Radiation-Sensitizing Agents--therapeutic use<br/>Remission Induction<br/>Triazoles--therapeutic use